LOGIN
Teriparatide Superior to Bisphosphonates for Fracture Incidence in Post-Menopausal Osteoporosis
October 2020
Teriparatide Superior to Bisphosphonates for Fracture Incidence in Post-Menopausal Osteoporosis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis.
Medicine (Baltimore). 2020 Apr; 99(15): e18964.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Fourteen studies were included in this meta-analysis comparing teriparatide and bisphosphonates for the improvement in bone mineral density and reduction of fracture incidence in postmenopausal women with osteoporosis. The outcomes of interest included the pooled incidence of vertebral and nonvertebral fractures, bone mineral density of the lumbar spine and femoral neck, and the incidence of adver...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.